Company news
Disc Medicine, Inc. news in 2022
Disc Medicine, Inc.'s news releases, calls and decks from 2022, newest first.
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria
December 26, 2022
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)
October 30, 2022
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
August 9, 2022
Gemini Therapeutics Reports 2021 Financial Results
March 9, 2022
Gemini Therapeutics Provides Corporate Update
February 27, 2022
Gemini Therapeutics Provides GEM103 Program Update
January 9, 2022
Decks in 2022
- Gemini Therapeutics — Merger or Acquisition (August 2022)
Merger or acquisition · 52 slides · Aug 10, 2022